Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient

Ingrid Hopper1, William Kemp, Pornwalee Porapakkham

  • 1Department of Clinical Pharmacology and Therapeutics, The Alfred Center, Melbourne, Australia. ingrid.hopper@monash.edu

Insights

Cardiac dysfunction increases liver stiffness (LSM) as measured by FibroScan(®), indicating potential liver issues in heart failure patients. Acute volume changes did not significantly alter LSM measurements in this study.

Area of Science:

  • Cardiology
  • Hepatology
  • Medical Diagnostics

Background:

  • Cardiac dysfunction can lead to cardiac hepatopathy, potentially causing hepatic fibrosis or cirrhosis.
  • The reliability of non-invasive tools like FibroScan(®) for assessing liver stiffness (LSM) in cardiac dysfunction is not well-established.
  • Understanding LSM variations in heart failure is crucial for managing liver complications.

Purpose of the Study:

  • To evaluate the impact of cardiac dysfunction on liver stiffness measurements (LSM) using FibroScan(®).
  • To investigate the influence of acute volume status changes on LSM in patients with heart failure and in those undergoing hemodialysis.

Main Methods:

  • A prospective, cross-sectional study involving patients with left-sided heart failure (LHF), right-sided heart failure (RHF), and acute decompensated heart failure (ADHF).
  • Liver stiffness was measured using FibroScan(®) in patient groups and compared to healthy controls.
  • LSM was reassessed after diuresis in ADHF patients and after ultrafiltration in a hemodialysis (HD) group to assess the impact of volume changes.

Main Results:

  • Patients with LHF, RHF, and ADHF showed significantly increased LSM compared to healthy controls.
  • Specifically, RHF and ADHF groups exhibited markedly elevated LSM.
  • Diuresis in ADHF patients and ultrafiltration in HD patients did not result in statistically significant alterations in LSM.

Conclusions:

  • Increased liver stiffness measurements are observed in patients with cardiac dysfunction.
  • Acute changes in volume status do not appear to significantly affect LSM readings in the context of heart failure or hemodialysis.
Abstract

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...